Mao C - Search Results

1

Predictive and prognostic value of KRAS mutations in metastatic colorectal cancer patients treated with cetuximab: a meta-analysis of 22 studies.

Qiu LX, Mao C, Zhang J, Zhu XD, Liao RY, Xue K, Li J, Chen Q. Qiu LX, et al. Among authors: mao c. Eur J Cancer. 2010 Oct;46(15):2781-7. doi: 10.1016/j.ejca.2010.05.022. Epub 2010 Jun 25. Eur J Cancer. 2010. PMID: 20580219 Review.

2

ATG16L1 T300A polymorphism and Crohn's disease susceptibility: evidence from 13,022 cases and 17,532 controls.

Zhang HF, Qiu LX, Chen Y, Zhu WL, Mao C, Zhu LG, Zheng MH, Wang Y, Lei L, Shi J. Zhang HF, et al. Among authors: mao c. Hum Genet. 2009 Jun;125(5-6):627-31. doi: 10.1007/s00439-009-0660-7. Epub 2009 Apr 1. Hum Genet. 2009. PMID: 19337756

3

Association between Fc receptor-like 3 C169T polymorphism and risk of systemic lupus erythematosus: a meta-analysis.

Mao C, Pan H, Chen Q, Wang X, Ye D, Qiu L. Mao C, et al. Mol Biol Rep. 2010 Jan;37(1):191-6. doi: 10.1007/s11033-009-9591-6. Epub 2009 Jun 30. Mol Biol Rep. 2010. PMID: 19565352

4

Serum p53 protein and anti-p53 antibodies are associated with increased cancer risk: a case-control study of 569 patients and 879 healthy controls.

Wu M, Mao C, Chen Q, Cu XW, Zhang WS. Wu M, et al. Among authors: mao c. Mol Biol Rep. 2010 Jan;37(1):339-43. doi: 10.1007/s11033-009-9744-7. Epub 2009 Aug 20. Mol Biol Rep. 2010. PMID: 19693693

5

TGFBR1*6A/9A polymorphism and cancer risk: a meta-analysis of 13,662 cases and 14,147 controls.

Liao RY, Mao C, Qiu LX, Ding H, Chen Q, Pan HF. Liao RY, et al. Among authors: mao c. Mol Biol Rep. 2010 Oct;37(7):3227-32. doi: 10.1007/s11033-009-9906-7. Epub 2009 Nov 1. Mol Biol Rep. 2010. PMID: 19882361

6

Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: a meta-analysis involving 46,281 subjects.

Qiu LX, Yuan H, Yu KD, Mao C, Chen B, Zhan P, Xue K, Zhang J, Hu XC. Qiu LX, et al. Among authors: mao c. Breast Cancer Res Treat. 2010 Jun;121(3):703-8. doi: 10.1007/s10549-009-0636-2. Epub 2009 Nov 21. Breast Cancer Res Treat. 2010. PMID: 19936916

7

MnSOD Val16Ala polymorphism and prostate cancer susceptibility: a meta-analysis involving 8,962 subjects.

Mao C, Qiu LX, Zhan P, Xue K, Ding H, Du FB, Li J, Chen Q. Mao C, et al. J Cancer Res Clin Oncol. 2010 Jul;136(7):975-9. doi: 10.1007/s00432-009-0742-x. Epub 2009 Dec 10. J Cancer Res Clin Oncol. 2010. PMID: 20012093

8

KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: a meta-analysis of 22 studies.

Mao C, Qiu LX, Liao RY, Du FB, Ding H, Yang WC, Li J, Chen Q. Mao C, et al. Lung Cancer. 2010 Sep;69(3):272-8. doi: 10.1016/j.lungcan.2009.11.020. Epub 2009 Dec 22. Lung Cancer. 2010. PMID: 20022659

9

Lack of association between CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis of 22,090 cases and 28,498 controls.

Mao C, Wang XW, He BF, Qiu LX, Liao RY, Luo RC, Chen Q. Mao C, et al. Breast Cancer Res Treat. 2010 Jul;122(1):259-65. doi: 10.1007/s10549-009-0695-4. Epub 2009 Dec 24. Breast Cancer Res Treat. 2010. PMID: 20033766

10

XRCC3 5'-UTR and IVS5-14 polymorphisms and breast cancer susceptibility: a meta-analysis.

Qiu LX, Mao C, Yao L, Yu KD, Zhan P, Chen B, Liu HG, Yuan H, Zhang J, Xue K, Hu XC. Qiu LX, et al. Among authors: mao c. Breast Cancer Res Treat. 2010 Jul;122(2):489-93. doi: 10.1007/s10549-009-0726-1. Epub 2010 Jan 5. Breast Cancer Res Treat. 2010. PMID: 20049524 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,891 results

Search Page

Filters